Ex Parte HERSH - Page 15


                  Appeal No. 2001-1177                                                         Page 15                     
                  Application No. 08/781,868                                                                               

                         expected to increase the healing properties of the composition,                                   
                         therefore, the invention as a whole is prima facie obvious. . . .                                 
                  Examiner’s Answer, page 18.                                                                              
                         We reverse this rejection.  The examiner characterizes the rejected claims                        
                  as directed to a “method of repairing free radical damage.”  However, the claims                         
                  do not encompass a method of repairing any free radical damage, but are limited                          
                  to a “method for enhancing repair from free radical damage to skin as a result of                        
                  treatment of the skin with exfoliants, chemosurgery or laser therapy.”  This                             
                  preamble language constitutes a limitation of the claimed method, because it                             
                  excludes from the scope of the claimed method treatment of patients other than                           
                  those who have suffered free radical damage to their skin as a result of                                 
                  exfoliants, chemosurgery, or laser therapy.  Thus, although the preamble did not                         
                  further limit the composition claims, it does limit the method claims.  The                              
                  examiner has pointed to nothing in the relied-on references that suggests that                           
                  any of the disclosed agents are useful in treating skin damaged by exfoliants,                           
                  chemosurgery or laser therapy.  Thus, the examiner has not shown that the                                
                  methods of claims 45-54 would have been prima facie obvious in view of the                               
                  prior art.                                                                                               
                                                        Summary                                                            
                         The composition of claim 35 is anticipated by both the claims and                                 
                  disclosure of Hersh.  The composition is also rendered obvious by the                                    
                  disclosures of N’Guyen and Burke.  We, therefore, affirm the rejections of claim                         
                  35 for obviousness-type double patenting, anticipation, and obviousness.  Claims                         






Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007